| Authors: |
Matsubara N; National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: nmatsuba@east.ncc.go.jp., Petrylak D; Yale Cancer Center, New Haven, CT, USA., Ratta R; Hôpital Foch, Suresnes, France., Korbenfeld E; Hospital Británico de Buenos Aires, Buenos Aires, Argentina., Gafanov R; Russian Scientific Center of Roentgenoradiology, Moscow, Russia., Mourey L; Oncopole Claudius Regaud - IUCT, Toulouse, France., Todenhöfer T; Studienpraxis Urologie, Nürtingen, Germany., Gurney H; Macquarie University, Sydney, NSW, Australia., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Bergman AM; Netherlands Cancer Institute, Amsterdam, The Netherlands., Zalewski P; Lakeridge Health, Oshawa, ON, Canada., Santis M; Department of Urology, Medical University of Vienna, Vienna, Austria; Charité Universitätsmedizin Berlin, Berlin, Germany., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Gerritsen W; Radboud University Medical Center, Nijmegen, The Netherlands., Pachynski RK; Washington University School of Medicine, St. Louis, MO, USA., Saretsky TL; Merck & Co. Inc., Rahway, NJ, USA., Ghate SR; Merck & Co. Inc., Rahway, NJ, USA., Wang F; MSD R&D (China) Co. Ltd, Beijing, China., Schloss C; Merck & Co. Inc., Rahway, NJ, USA., Fizazi K; Gustave Roussy, University of Paris-Saclay, Villejuif, France. |
